Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe save search
SIPUP ANNOUNCES APPOINTMENT OF VP FOR BUSINESS DEVELOPMENT IN EUROPE
Published: 2022-04-06 (Crawled : 18:00) - prnewswire.com
SPUP | $0.0003 94966.67% 1.1K
|
| Email alert
Add to watchlist
europe
Adhera Receives European Patent Covering MLR-1019 and Derivatives for Treating Dyskinesias
Published: 2021-10-04 (Crawled : 14:00) - globenewswire.com
ATRX | News | $0.006 1724.82% 300
|
Manufacturing
|
| O: 4.9%
H: 0.0%
C: -8.33%
europe patent skin
Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
YUMAQ | $0.0001 900.0% 750
|
Mining, Quarrying, and Oil and ...
| Email alert
Add to watchlist
Relief Therapeutics to Participate in Virtual Investor Conferences in January 2022
Published: 2022-01-05 (Crawled : 12:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 30.48%
H: 11.16%
C: 6.0%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: 39.14%
H: 3.86%
C: 3.26%
conference therapeutics
Relief Reports that its U.S. Collaboration Partner has Announced the Filing of a Provisional Patent Application for Stable Compositions of Aviptadil Suitable for Human Use
Published: 2022-01-04 (Crawled : 10:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 8.45%
H: 6.1%
C: 6.1%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: 10.09%
H: 0.0%
C: 0.0%
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 6.8%
H: 0.0%
C: 0.0%
aviptadil application patent collaboration
Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies
Published: 2022-01-19 (Crawled : 10:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 1.51%
H: 3.09%
C: -1.37%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -6.53%
H: 3.29%
C: 3.29%
covid-19 aviptadil expansion program respiratory covid report collaboration
Relief Announces U.S. Launch of PKU GOLIKE
Published: 2022-10-10 (Crawled : 14:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 1.05%
H: 5.56%
C: -6.25%
Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate
Published: 2022-10-03 (Crawled : 13:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -23.08%
H: 42.86%
C: 30.95%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 2.88%
H: 1.4%
C: -0.35%
patent application therapeutics
Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago
Published: 2022-09-22 (Crawled : 07:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -20.21%
H: 40.17%
C: 33.19%
trial approval therapeutics initiated
RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. Extend Their Stay of Pending Litigation to Provide Additional Time for The Parties to Finalize Their Settlement
Published: 2022-10-26 (Crawled : 13:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -13.46%
H: 28.44%
C: 20.0%
therapeutics
Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.
Published: 2022-10-06 (Crawled : 07:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 0.0%
H: 3.75%
C: 2.39%
Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment
Published: 2022-02-16 (Crawled : 09:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -7.15%
H: 7.7%
C: 6.89%
covid-19 aviptadil health covid report collaboration enroll
Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from Right to Try Use of Aviptadil During Omicron Surge
Published: 2022-01-27 (Crawled : 11:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -0.4%
H: 3.91%
C: -4.18%
aviptadil report collaboration
Relief Files Trademark Application for RLF-100 With the U.S. Patent and Trademark Office
Published: 2022-02-08 (Crawled : 08:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -0.78%
H: 2.37%
C: -0.66%
rlf-100 ema application patent 100
Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil
Published: 2022-04-22 (Crawled : 09:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -2.1%
H: 3.39%
C: -0.89%
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -15.09%
H: 1.67%
C: -5.56%
designation collaboration aviptadil therapy
Relief Therapeutics Reports In Vivo Data Indicating Prolonged Release of Amino Acids Using its Physiomimic(TM) Technology May Have Benefits for the Treatment of PKU
Published: 2022-03-28 (Crawled : 08:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -1.85%
H: 3.62%
C: 2.9%
treatment technology therapeutics
Relief Therapeutics Provides an Update on its Financing Strategy
Published: 2023-02-08 (Crawled : 11:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 15.24%
H: 0.0%
C: -20.39%
therapeutics update
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
Published: 2023-01-17 (Crawled : 11:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -8.26%
H: 14.0%
C: 10.0%
td011 treatment t-cell trial approval therapeutics
Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access
Published: 2022-08-17 (Crawled : 07:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -2.78%
H: 8.57%
C: 4.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.36%
H: 0.45%
C: -0.97%
MIRM | News | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.0%
H: 2.38%
C: -0.49%
therapeutics market
RELIEF THERAPEUTICS HOLDING SA AND NRX PHARMACEUTICALS, INC. ANNOUNCE TENTATIVE SETTLEMENT OF PENDING LITIGATION
Published: 2022-08-22 (Crawled : 17:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: -4.24%
H: 4.42%
C: 0.29%
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -3.02%
H: 5.38%
C: -0.65%
tentative therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.